Clinical Trial Update: Clinical Trial of SBRT and Systemic Pembrolizumab With or Without Avelumab/Ipilimumab+ Dendritic Cells in Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating SBRT with pembrolizumab, with or without avelumab/ipilimumab and dendritic cells, in solid tumors including non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumor

Drugs mentioned

• Avelumab (avelumab)
• Dendritic cells
• Pembrolizumab (pembrolizumab)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non Small Cell Lung Cancer, Solid Tumor | Phase 2 | Status: UNKNOWN